NCT06895408View on ClinicalTrials.gov

Separate and Combined Extrapancreatic Effects of GIP and GLP-1

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 19, 2025

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
Pancreatectomy; Hyperglycemia
Interventions
OTHER

Intravenous Infusion

Glucose-dependent Insulinotropic Polypeptide

OTHER

Intravenous Infusion

Glucagon-Like Peptide 1

OTHER

Intravenous Infusion

Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide 1

OTHER

Intravenous Infusion

Saline

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER

NCT06895408 - Separate and Combined Extrapancreatic Effects of GIP and GLP-1 | Biotech Hunter | Biotech Hunter